BioMarin Pharmaceutical | BMRN - EPS Earnings Per Share

Stock Price
53.81
Daily Change
0.51 0.96%
Monthly
-1.79%
Yearly
-15.51%
Q2 Forecast
52.04

BioMarin Pharmaceutical reported $0.46 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.74 1.13 May/04
FY2025Q4 Dec/2025 0.46 0.77 0.92 Feb/23
FY2025Q3 Sep/2025 0.12 0.86 0.91 Oct/27
FY2025Q2 Jun/2025 1.44 0.84 0.96 Aug/04
FY2025Q1 Mar/2025 1.13 0.65 0.71 May/01




Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Bayer EUR 0.62 0.05 Dec/2025
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Incyte USD 1.81 0.01 Mar/2026
Insmed USD -1.54 0.21 Dec/2025
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Moderna USD -2.11 1.6 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 2.17 2.84 Mar/2026
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
United Therapeutics USD 7.7 0.54 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025